SOPHiA Genetics SA

SOPHiA Genetics SA

Health Care Technology
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

$669.1M

Market Cap • 11/10/2026

2011

(15 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Switzerland

Switzerland

Country

Valuation

P/B

9,8

P/S

7,4

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

0,8

EPS

—

Market Cap

Market Cap

669,1M

EV

636,5M

EV/Revenue

7

EV/EBITDA

-10,1

EV/EBIT

-8,6

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-10,8%

Total Yield

-10,8%

Payout

0%

Retained Earnings

-581,2M

Profitability

Gross Margin

66,4%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

38,5%

Capex/Revenue

1,2%

Capex/D&A

10%

Capex/OCF

-2,7%

SBC/OCF

—

% PPE

7,9%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

19,5%

CAGR Op. Income 5Y

3,6%

CAGR Net Income 5Y

5,3%

CAGR EPS 5Y

2,5%

CAGR OCF 5Y

-5%

Leverage

N.D./EBITDA

0,5

Debt/Equity

0%

Current Ratio

2,3

Quick Ratio

2

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium